Audits Set to Resume August 3, Updated FAQs On COVID-19 Provider Burden Relief

Published in Women's Health on July 20, 2020

August 3 seems to be an important date for CMS. On August 3, the DME MACs, SMRC, and RAC will be able to resume audit activity. 

Here is a recent update from the “Coronavirus Disease 2019 (COVID-19) Provider Burden Relief Frequently Asked Questions (FAQs)” that are attached as well.  Prior Authorizations will resume as business as usual for PMDs and Group 2 Support Surfaces.  Also, the lower limb prosthetics (6 codes) will begin prior authorization activity with a phased approach with Phase 1 starting Sept 1, 2020.

If you have questions about these updates, contact Ronda Buhrmester.

Q. Is CMS suspending most Medicare Fee-For-Service (FFS) medical review during the Public Health Emergency (PHE) for the COVID-19 pandemic?

A. On March 30th, CMS suspended most Medicare Fee-For-Service (FFS) medical review because of the COVID-19 pandemic. This included pre-payment medical reviews conducted by Medicare Administrative Contractors (MACs) under the Targeted Probe and Educate program, and post-payment reviews conducted by the MACs, Supplemental Medical Review Contractor (SMRC) reviews and Recovery Audit Contractor (RAC). As states reopen and given the importance of medical review activities to CMS’ program integrity efforts, CMS expects to discontinue exercising enforcement discretion beginning on August 3, 2020, regardless of the status of the public health emergency. If selected for review, providers should discuss with their contractor any COVID-19-related hardships they are experiencing that could affect audit response timeliness. CMS notes that all reviews will be conducted in accordance with statutory and regulatory provisions, as well as related billing and coding requirements. Waivers and flexibilities in place at the time of the dates of service of any claims potentially selected for review will also be applied

Q. When is CMS resuming the Prior Authorization Program for DMEPOS items?

A. Given the importance of medical review activities to CMS’ program integrity efforts, CMS expects to discontinue exercising enforcement discretion beginning on August 3, 2020, regardless of the status of the public health emergency. CMS will resume full operations for the prior authorization program for certain DMEPOS items. For Power Mobility Devices and Pressure Reducing Support Surfaces that require prior authorization as a condition of payment, claims with an initial date of service on or after August 3, 2020, must be associated with an affirmative prior authorization decision to be eligible for payment. For an updated list of items that require prior authorization please visit: https://www.cms.gov/Research-Statistics-Data-and-Systems/Monitoring-Programs/Medicare-FFS-Compliance-Programs/DMEPOS/Downloads/DMEPOS_PA_Required-Prior-Authorization-List.pdf 


TAGS

  1. covid-19
  2. essentially women
  3. women's health

From Our Experts

Protecting Your Business With Viable and Sustainable Payer Contracts thumbnail Protecting Your Business With Viable and Sustainable Payer Contracts Read how to protect your durable medical equipment, prosthetic, orthotic, and supplies (DMEPOS) business by ensuring that you have payer contracts that have long-term viability, as this is one of the most important factors in determining whether your company ultimately succeeds or fails. Locking the Digital Door to Risk: Proactive IT and Website Security Strategies to Protect Your Business thumbnail Locking the Digital Door to Risk: Proactive IT and Website Security Strategies to Protect Your Business With the increasing number of cyber threats and data breaches, it's important to take the necessary steps to protect your business from these risks. The PHE Is Over: What's Next? thumbnail The PHE Is Over: What's Next? In today's episode of Industry Matters, Mandi Joyner, Senior Director of Marketing at VGM & Associates, talks with three of VGM's payer, billing, and reimbursement experts Ronda Buhrmester, Dan Fedor, and Craig Douglas about the end of the Public Health Emergency (PHE) and what that means for members. How to Navigate Supply Chain Issues thumbnail How to Navigate Supply Chain Issues The DMEPOS supply chain was significantly disrupted by the COVID-19 pandemic, and the industry is gradually making its way back to a more typical state. Nevertheless, certain procedures that were developed out of necessity during the pandemic's onset and peak have evolved into effective best practices. One of the most crucial lessons learned is the importance of close collaboration between providers and their trusted vendors, manufacturers, or distributors to ensure success. The State of DMEPOS: Where Does Our Industry Stand Now, and Where Are We Heading? thumbnail The State of DMEPOS: Where Does Our Industry Stand Now, and Where Are We Heading? Jeremy Stolz, President, VGM & Associates and VGM Fulfillment, outlines several areas of the DMEPOS industry to consider as part of your business' action plan for 2023. VGM & Associates Releases Latest Playbook on Safeguarding Your Future in DMEPOS thumbnail VGM & Associates Releases Latest Playbook on Safeguarding Your Future in DMEPOS VGM & Associates has released the second playbook of 2023, “VGM Playbook: Safeguarding Your Future in DMEPOS.” Essentially Women Announces Website Redesign thumbnail Essentially Women Announces Website Redesign Essentially Women (EW), a division of VGM & Associates, is excited to unveil their newly redesigned website, essentiallywomen.com. Overcoming Staffing Changes One Piece at a Time thumbnail Overcoming Staffing Changes One Piece at a Time VGM member Jim Lehan, Business Operations Director, Lehan Drugs Inc., describes how his business improved their staffing challenges through hiring and retention, automation, and outsourcing.